Lessons from TGF-β Transgenic Mice

No abstract is available for this paper.

• Publication year

  1998

• Venue

  Mineral and Electrolyte Metabolism

• Publication date

  1998-02-23

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1159/000057364
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar

• No claims are published for this paper.

• No concepts are published for this paper.

• Site-directed Mutagenesis of Cysteine Residues in the Pro Region of the Transforming Growth Factor 81 Precursor EXPRESSION AND CHARACTERIZATION MUTANT PROTEINS*

  2001cited by this paper
• Biology of TGF-β in knockout and transgenic mouse models

  1997cited by this paper
• Expression of a dominant‐negative mutant TGF‐β type II receptor in transgenic mice reveals essential roles for TGF‐β in regulation of growth and differentiation in the exocrine pancreas

  1997cited by this paper
• Arrested lung morphogenesis in transgenic mice bearing an SP-C-TGF-beta 1 chimeric gene.

  1996cited by this paper
• Transforming growth factor-beta fails to inhibit allograft rejection or virus-induced autoimmune diabetes in transgenic mice.

  1996cited by this paper
• Spontaneously increased production of nitric oxide and aberrant expression of the inducible nitric oxide synthase in vivo in the transforming growth factor beta 1 null mouse

  1996cited by this paper
• TGFb1 Inhibits the Formation of Benign Skin Tumors, but Enhances Progression to Invasive Spindle Carcinomas in Transgenic Mice

  1996cited by this paper
• Increased expression of TGF-beta 2 in osteoblasts results in an osteoporosis-like phenotype

  1996cited by this paper
• Tumor suppressor activity of the TGF-β pathway in human cancers

  1996cited by this paper
• Altered epidermal cell growth control in vivo by inducible expression of transforming growth factor beta 1 in the skin of transgenic mice.

  1996cited by this paper
• The recombinant proregion of transforming growth factor beta1 (latency-associated peptide) inhibits active transforming growth factor beta1 in transgenic mice.

  1996cited by this paper
• SLE-like autoantibodies and Sjögren's syndrome-like lymphoproliferation in TGF-beta knockout mice.

  1995cited by this paper
• Mammary tumor suppression by transforming growth factor beta 1 transgene expression.

  1995cited by this paper
• Concerted action of TGF-beta 1 and its type II receptor in control of epidermal homeostasis in transgenic mice.

  1995cited by this paper
• The serum concentration of active transforming growth factor-β is severely depressed in advanced atherosclerosis

  1995cited by this paper
• Specific binding of endocrine transforming growth factor-beta 1 to vascular endothelium.

  1995cited by this paper
• Hepatic expression of mature transforming growth factor beta 1 in transgenic mice results in multiple tissue lesions.

  1995cited by this paper
• Transforming growth factor-beta in human cutaneous leishmaniasis.

  1995cited by this paper
• Transforming growth factor‐β: activity and efficacy in animal models of wound healing

  1995cited by this paper
• Accumulation of extracellular matrix and developmental dysregulation in the pancreas by transgenic production of transforming growth factor-beta 1.

  1995cited by this paper
• Elevated plasma levels of TGF-β1 in patients with invasive prostate cancer

  1995cited by this paper
• Increased central nervous system production of extracellular matrix components and development of hydrocephalus in transgenic mice overexpressing transforming growth factor-beta 1.

  1995cited by this paper
• TGF-beta 1 overexpression in murine pancreas induces chronic pancreatitis and, together with TNF-alpha, triggers insulin-dependent diabetes.

  1995cited by this paper
• Overexpression of TGF‐β1 in the Central Nervous System of Transgenic Mice Results in Hydrocephalus

  1995cited by this paper
• Transforming Growth Factor-β1 Circulates in Normal Human Plasma and is Unchanged in Advanced Metastatic Breast Cancer

  1995cited by this paper
• TGF beta 1 inhibits branching morphogenesis and N-myc expression in lung bud organ cultures.

  1994cited by this paper
• Thrombospondin binds and activates the small and large forms of latent transforming growth factor-beta in a chemically defined system.

  1994cited by this paper
• The glomerular response to injury: progression or resolution?

  1994cited by this paper
• Transforming Growth Factor β in Tissue Fibrosis

  1994cited by this paper
• Expression of transforming growth factor-β1,2, and 3 mRNA and protein in human cancers

  1994cited by this paper
• Transforming growth factor beta in tissue fibrosis.

  1994cited by this paper
• The biology of the glomerulus: endothelial cells.

  1994cited by this paper
• Experimental insights into the tubulointerstitial disease accompanying primary glomerular lesions.

  1994cited by this paper
• Plasma transforming growth factor-beta 1 in patients with hepatocellular carcinoma. Comparison with chronic liver diseases.

  1994cited by this paper
• Transforming Growth Factor β as a Predictor of Liver and Lung Fibrosis after Autologous Bone Marrow Transplantation for Advanced Breast Cancer

  1993cited by this paper
• Activation of latent transforming growth factor beta.

  1993cited by this paper
• Inhibition of mammary duct development but not alveolar outgrowth during pregnancy in transgenic mice expressing active TGF-beta 1.

  1993cited by this paper
• Targeting expression of a transforming growth factor beta 1 transgene to the pregnant mammary gland inhibits alveolar development and lactation.

  1993cited by this paper
• Inhibition of skin development by overexpression of transforming growth factor beta 1 in the epidermis of transgenic mice.

  1993cited by this paper
• Transforming growth factor beta as a predictor of liver and lung fibrosis after autologous bone marrow transplantation for advanced breast cancer.

  1993cited by this paper
• Activation of Latent Transforming Growth Factor ß

  1993cited by this paper
• Regulation of mammary morphogenesis: evidence for extracellular matrix-mediated inhibition of ductal budding by transforming growth factor-beta 1.

  1992cited by this paper
• Evidence of endogenous regulatory function of transforming growth factor-beta 1 in experimental allergic encephalomyelitis.

  1992cited by this paper
• Enhanced expression of transforming growth factor beta 1 in the rat brain after a localized cerebral injury.

  1992cited by this paper
• Regulated expression and growth inhibitory effects of transforming growth factor-beta isoforms in mouse mammary gland development.

  1991cited by this paper
• Latent forms of TGF-beta: molecular structure and mechanisms of activation.

  1991cited by this paper
• Protective effect of transforming growth factor beta 1 on experimental autoimmune diseases in mice.

  1991cited by this paper
• Autoinduction of transforming growth factor beta 1 is mediated by the AP-1 complex

  1990cited by this paper
• Transforming growth factor-beta and the initiation of chondrogenesis and osteogenesis in the rat femur

  1990cited by this paper
• Suppression of carcinogenesis: a role for TGF-beta and related molecules in prevention of cancer.

  1990cited by this paper
• In vivo stimulation of bone formation by transforming growth factor-beta.

  1989cited by this paper
• TGF-beta 1-induced inhibition of mouse mammary ductal growth: developmental specificity and characterization.

  1989cited by this paper
• Type beta transforming growth factor reversibly inhibits the early proliferative response to partial hepatectomy in the rat.

  1988cited by this paper

• Inhibition of class I HDACs attenuates renal interstitial fibrosis in a murine model

  2019cites this paper
• The Onset and Resolution of Renal Fibrosis: A Human Perspective

  2016cites this paper
• Nerve growth factor exposure promotes tubular epithelial–mesenchymal transition via TGF-β1 signaling activation

  2015cites this paper
• MicroRNA-21 in glomerular injury.

  2015cites this paper
• Bmi-1 plays a critical role in protection from renal tubulointerstitial injury by maintaining redox balance

  2014cites this paper
• Overlapping activities of TGF-β and Hedgehog signaling in cancer: therapeutic targets for cancer treatment.

  2013cites this paper
• Molecular targets for treatment of kidney fibrosis

  2012cites this paper
• Transgenic Expression of TGF-β on Thyrocytes Inhibits Development of Spontaneous Autoimmune Thyroiditis and Increases Regulatory T Cells in Thyroids of NOD.H-2h4 Mice

  2010cites this paper
• TGF-beta receptor deletion in the renal collecting system exacerbates fibrosis.

  2010cites this paper
• Invariant natural killer T cells and TGF-beta attenuate anti-GBM glomerulonephritis.

  2009cites this paper
• Transforming growth factor‐β in cutaneous melanoma

  2008cites this paper
• Transforming growth factor-b in cutaneous melanoma

  2008cites this paper
• Differential Effects of TGF-&bgr; Isoforms on Murine Fetal Dural Cells and Calvarial Osteoblasts

  2007cites this paper
• TGF-β in renal injury and disease

  2007cites this paper
• Inhibition of Gene Markers of Fibrosis with a Novel Inhibitor of Transforming Growth Factor-β Type I Receptor Kinase in Puromycin-Induced Nephritis

  2005cites this paper
• Augmented cytoplasmic Smad4 induces acceleration of TGF-β1 signaling in renal tubulointerstitial cells of hereditary nephrotic ICGN mice with chronic renal fibrosis; possible role for myofibroblastic differentiation

  2004cites this paper
• Regulation of Inducible Class II MHC, Costimulatory Molecules, and Cytokine Expression in TGF-β1 Knockout Renal Epithelial Cells: Effect of Exogenous TGF-β1

  2002cites this paper
• Mice and humans: chromosome engineering and its application to functional genomics.

  2002cites this paper
• Alteration of transforming growth factor-beta1 response involves down-regulation of Smad3 signaling in myofibroblasts from skin fibrosis.

  2001cites this paper
• Osteoblast Gene Expression is Differentially Regulated by TGF-&bgr; Isoforms

  2001cites this paper
• Inhibition of MMH (Met murine hepatocyte) cell differentiation by TGF(beta) is abrogated by pre-treatment with the heritable differentiation effector FGF1.

  2000cites this paper
• Smad proteins and transforming growth factor-β signaling

  2000cites this paper
• INTERACTIONS OF SMALL LATENT TRANSFORMING GROWTH FACTOR-BETAS WITH THEIR BINDING PROTEINS, LTBPs

  2000cites this paper
• Latent transforming growth factor-beta binding proteins (LTBPs)--structural extracellular matrix proteins for targeting TGF-beta action.

  1999cites this paper
• TGF-β1 down-regulates induced expression of both class II MHC and B7-1 on primary murine renal tubular epithelial cells

  1999cites this paper
• Transforming Growth Factor Beta Signal Transduction in the Kidney

  1998cites this paper